Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01013_DB05521_nanopub.RA56aVEMmH-0bbXJ4faAT7OSLIW0OK4Al7HVSMsKWkOKw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01013_DB05521 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01013_DB05521 label "DDI between Clobetasol propionate and Telaprevir - Corticosteroids such as clobetasol may decrease the serum concentration of telaprevir. Telaprevir may increase the serum concentration of corticosteroids. Concurrent use of telaprevir and systemic corticosteroids is not recommended. When possible, consider alternatives, and if such a combination is necessary, use extra caution, monitoring patients for excessive systemic steroid effects as well as for diminished telaprevir effects. [drugbank_resource:DB01013_DB05521]" assertion.
- drugbank_resource:DB01013_DB05521 identifier "drugbank_resource:DB01013_DB05521" assertion.
- drugbank_resource:DB01013_DB05521 title "DDI between Clobetasol propionate and Telaprevir - Corticosteroids such as clobetasol may decrease the serum concentration of telaprevir. Telaprevir may increase the serum concentration of corticosteroids. Concurrent use of telaprevir and systemic corticosteroids is not recommended. When possible, consider alternatives, and if such a combination is necessary, use extra caution, monitoring patients for excessive systemic steroid effects as well as for diminished telaprevir effects." assertion.
- drugbank:DB05521 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01013_DB05521 assertion.
- drugbank:DB01013 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01013_DB05521 assertion.